CTMX
CytomX Therapeutics Inc.
$3.57
+$0.24(+7.21%)
71
Overall
80
Value
63
Tech
--
Quality
Market Cap
$326.53M
Volume
2.77M
52W Range
$0.40 - $3.91
Target Price
$6.14
Key Metrics Overview
| Market Cap | $326.53M | P/E Ratio | 71.40 |
| 52W High | $3.91 | 52W Low | $0.40 |
| Div Yield | N/A | Payout Ratio | 0.0% |
| EPS Growth 3Y | 31.9% | 52W Position | 90.3% |
| Overall Score | 71 | Value Score | 80 |
| Quality Score | -- | Technical Score | 63 |
Growth Analysis
| EPS Current Est | $0.05 | EPS Next Est | $-0.29 |
| EPS Growth Est | -680.0% | DPS Growth 3Y | N/A |
Revenue (5Y)
EBITDA (5Y)
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | CTMX | $3.57 | +7.2% | 2.77M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get CytomX Therapeutics Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW